Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Molecular mechanisms and therapeutic perspectives in vulvodynia: From current evidence to future investigations.

Created on 25 Sep 2026

Authors

Alessia Albano, Luna Brasi, Federica Loperfido, Gloria Griffante, Marco Amato Cianci, Giacomo Donati, Valentina Proserpio

Published in

Cell reports. Medicine. Volume 7. Issue 8. Pages 102917. Aug 18, 2026. Epub Jul 10, 2026.

Abstract

Vulvodynia is defined as chronic vulvar pain persisting for at least 3 months without a clear identifiable cause. It affects 10%-16% of women, and despite its high prevalence and the severity of symptoms, vulvodynia remains significantly understudied. Here, we consolidate and analyze the scientific literature from the past 25 years, addressing vulvodynia from a molecular perspective. Following an overview of the female genital anatomy, we use a top-down approach to examine in depth the key determinants associated with this disease from the macroscopic to the microscopic scale, such as cellular components, microbiota diversity, hormones, cytokines, receptors, and genetic predispositions. We summarize existing and potential therapeutic strategies, highlighting the importance of further research. Key functional aspects, such as the interactions between the nervous system, immune system, and microbiota, remain to be elucidated. Across published studies, immune system dysfunction emerges as the most consistently reported factor and may contribute to disease development and maintenance.

PMID:
42431194
Bibliographic data and abstract were imported from PubMed on 25 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement